A reduction of SCFAs-producing bacteria leading to SCFAs deficiency may result in detrimental effects in PD patients, including gut leakiness, increased colonic inflammation, increased risk of α-synuclein deposition in the gastrointestinal tract, and microglial activation in the brain (68, 69). Here, SNCA is linked to Parkinson disease.